{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:47:20Z","timestamp":1760057240694,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ajem.2020.07.079","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T20:29:35Z","timestamp":1596486575000},"page":"282-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sunitinib-associated hyperammonemic encephalopathy"],"prefix":"10.1016","volume":"46","author":[{"given":"Demis N.","family":"Lipe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Besim","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2020.07.079_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2019.03.007","article-title":"Risk of fatal adverse events in cancer patients treated with Sunitinib","volume":"137","author":"Zhao","year":"2019","journal-title":"Crit Rev in Oncol Hematol"},{"key":"10.1016\/j.ajem.2020.07.079_bb0010","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12029-018-0067-6","article-title":"Multi-targeted tyrosine kinase inhibitor-induced hyperammonemic encephalophaty: a report of two cases using Pazopanib, Sunitinib, and Regorafenib","volume":"50","author":"Kongsuphon","year":"2019","journal-title":"J Gastrointest Cancer"},{"author":"U.S. National Library of Medicine","key":"10.1016\/j.ajem.2020.07.079_bb0015"},{"key":"10.1016\/j.ajem.2020.07.079_bb0020","first-page":"e1","article-title":"Pearls & Oy-sters: Chemotherapy-associated hyperammonemic encephalopathy","volume":"94","author":"Briard","year":"2020","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.ajem.2020.07.079_bb0025","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1Q038","article-title":"Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors","volume":"45","author":"Lee","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajem.2020.07.079_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12054","article-title":"Sunitinib-induced hyperammonaemia in a patient with pancreatic neuroendocrine tumour","volume":"38","author":"Shea","year":"2013","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.ajem.2020.07.079_bb0035","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jpainsymman.2014.01.002","article-title":"Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy","volume":"47","author":"Shinde","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.ajem.2020.07.079_bb0040","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1097\/MJT.0b013e3182a32e0e","article-title":"A rare case of Sunitinib-induced hyperammonemic encephalopathy and hypothyroidism in metastatic renal cell carcinoma","volume":"23","author":"Pilanci","year":"2016","journal-title":"Am J Ther"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720306744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720306744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:59:34Z","timestamp":1760025574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720306744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":8,"alternative-id":["S0735675720306744"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.07.079","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sunitinib-associated hyperammonemic encephalopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.07.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}